HRMY - Harmony Biosciences ...

Harmony Biosciences Holdings, Inc.

HRMY

NASDAQ

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

32.72 USD

0 (0%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

PPE Schedule

Year

2024

2023

2022

2021

Gross PPE

1.26M

371k

573k

820k

Annual Depreciation

24.11M

24.36M

23.39M

18.84M

Capital Expenditure

-1.15M

-312k

-40.17M

-100.3M

Net PPE

-21.7M

-23.68M

17.36M

82.28M

All figures are in USD.

All Income Statement Balance Sheet Statement Cash Flow Statement Retained Earning Schedule PPE Schedule Intangible and Goodwill Schedule

FMP

Home Terms of Service Privacy Policy Blog Careers FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.